CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

DR REDDYS LABORATORIES LTD

RDY
$10.37BLarge Cap

Next catalyst

PDUFADecember 2026

abatacept (biosimilar)

Get an email about RDY's next catalysts

Track DR REDDYS LABORATORIES (RDY) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.

Plus 1 more upcoming event in our data (company event).See the timeline

Catalyst Timeline

2 upcoming, 1 past

Other

Other - semaglutide

Nov 1, 2026

Dr. Reddy's outlined plans to relaunch semaglutide in November 2026 and reiterated its target of 6M-7M devices.

Source
PDUFANext

FDA PDUFA Date abatacept (biosimilar) (standard)

December 2026~abatacept (biosimilar)

aBLA filing. Extracted from SEC filing: EXHIBIT 99.1

Source

How RDY's past catalysts played out

Market Overview

Stock performance and key metrics

NASDAQPharmaceutical PreparationsPharmaceuticalsπŸ‡ΊπŸ‡ΈNorth AmericaHYDERABAD24.8K employees

Dr. Reddy's Laboratories Ltd. is an Indian multinational pharmaceutical company based in Hyderabad, with U.S. headquarters in East Brunswick, New Jersey. The company was founded by Kallam Anji Reddy, who previously worked in the mentor institute Indian Drugs and Pharmaceuticals Limited. Dr. Reddy's manufactures and markets a wide range of pharmaceuticals in India and overseas. The company produces over 190 medications, 60 active pharmaceutical ingredients (APIs) for drug manufacture, diagnostic kits, critical care, and biotechnology.

Website
Drug Pipeline

Frequently asked questions

What is in DR REDDYS LABORATORIES LTD's drug pipeline?β†’

CatalystAlert tracks 2 drug candidates in DR REDDYS LABORATORIES LTD's (RDY) pipeline across Phase 2. Its lead program is DFD05 Cream (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.

When is DR REDDYS LABORATORIES LTD's next FDA catalyst?β†’

DR REDDYS LABORATORIES LTD's (RDY) next tracked catalyst is a PDUFA date expected December 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.

How do I track RDY biotech catalysts?β†’

Add RDY to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow DR REDDYS LABORATORIES LTD's live catalyst calendar, drug pipeline and clinical-trial timeline on this page β€” sourced from ClinicalTrials.gov, FDA and SEC filings.

Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply